Effectiveness of the Family Portal Function on the Lilly Connected Care Program (LCCP) for Patients With Type 2 Diabetes: Retrospective Cohort Study With Propensity Score Matching

Yiyu Zhang   ^{1, 2} , MD ;   Chaoyuan Liu   ³ , MD ;   Shuoming Luo   ¹ , MD ;   Jin Huang   ¹ , MD ;   Yuxin Yang   ⁴ , MD ;   Xiao Ma   ⁴ , MD ;   Xia Li   ^{1 *} , MD ;   Zhiguang Zhou   ^{1 *} , MD

¹ National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology of Ministry of Education, Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China

² Department of Endocrinology, Changsha Central Hospital, Changsha, China

³ Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China

⁴ Lilly Suzhou Pharmaceutical Company, Suzhou, China

*these authors contributed equally